JAZZ PHA reported $-118655000 in EBITDA for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
ALKERMES ALKS:US USD 448K 41.49M
Amarin AMRN:US USD 2.2M 39.04M
Cara Therapeutics CARA:US USD -31246000 7.46M
Coherus Biosciences CHRS:US USD -50443000 29.01M
Emergent Biosolutions EBS:US USD -22600000 15M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Halozyme Therapeutics HALO:US USD 83.06M 29.83M
Heron Therapeutics HRTX:US USD -41176000 7.65M
Hikma Pharmaceutical HIK:LN USD 471M 122M
Horizon Pharma HZNP:US USD 313.74M 26.49M
IONIS PHARMACEUT IONS:US USD -204382000 149.65M
Mckesson MCK:US USD 1.4B 115M
Nektar Therapeutics NKTR:US USD -37707000 2.91M
Pacira Pharmaceuticals PCRX:US USD 44.76M 2.79M
Perrigo Ordinary Shares PRGO:US USD 138.4M 2.3M
Pfizer PFE:US USD 6.94B 3.94B
Phibro Animal Health PAHC:US USD 30.91M 8.78M
Revance Therapeutics RVNC:US USD -57156000 14.89M
Supernus Pharmaceuticals SUPN:US USD 55.83M 35.58M
Teva Pharmaceutical Industries TEVA:US USD 1.31B 245M
Xeris Pharmaceuticals Inc XERS:US USD -12059000 3.55M
Zoetis ZTS:US USD 817M 23M